What happens if Mitch McConnell can't finish his term?

What happens if Mitch McConnell can't finish his term?

[ad_1] Sen. Mitch McConnell’s hospitalization this week with flu-like symptoms has renewed attention not just to the 83-year-old’s health, but to a question with significant political ramifications: What happens if Kentucky’s senior senator cannot complete his term? [ad_2] Source link

Read More

Sundance Is a Feast of World Cinema

Sundance Is a Feast of World Cinema

[ad_1] Manuel’s approach to narrative is as original as his sense of cinematic form, and his gift for documentary-style observation is balanced by a refined sense of style. (He sketched this method and this story in a short film of the same title, which premièred at Sundance in 2020 and involves several of the same…

Read More

US software stocks hit by Anthropic wake-up call on AI disruption

US software stocks hit by Anthropic wake-up call on AI disruption

[ad_1] Published Thu, Feb 5, 2026 · 12:02 AM [NEW YORK] US software stocks extended their slide on Wednesday, driven by fears of disruption caused by artificial intelligence, with some analysts warning of more volatility as investors assess whether the challenge is existential for the sector. The sell-off was triggered by a new legal tool…

Read More

What is value-based pricing (and why it works for startups)

What is value-based pricing (and why it works for startups)

[ad_1] You finally have users. A few are paying. Some say the product is “cheap,” others ask for discounts, and a couple would probably pay more but you never tested it. Pricing suddenly feels heavier than features, because one wrong move affects revenue, positioning, and confidence all at once. This is where most founders start…

Read More

GSK profit lifted by HIV, asthma drugs in boost to new CEO

GSK profit lifted by HIV, asthma drugs in boost to new CEO

[ad_1] Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations Published Wed, Feb 4, 2026 · 11:13 PM [LONDON] GSK reported better-than-expected profit in the fourth quarter, buoyed by its human immunodeficiency virus (HIV) drugs and an asthma medicine that is now also approved for lung disease. Its adjusted earnings per share…

Read More